OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
– Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib
TARPON SPRINGS, Fla., September 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor— today provided an update on recent advances in its proprietary Drug Response Predictor (DRP®) technology, patent portfolio and in-house laboratory capabilities that strengthen its ability to drive stenoparib’s clinical development while expanding external partnership opportunities.
Allarity Therapeutics was established on its proprietary patient selection technology—the Drug Response Predictor (DRP®). DRP® allows Allarity to assess a patient’s tumor tissue for the gene expression changes that indicate the patient’s tumor is either more or less likely to respond to a given cancer therapy. DRP® tests have been successfully developed for dozens of cancer therapies. Most notably, DRP® has been developed for Allarity’s lead asset, stenoparib, and has been deployed in the clinic to pre-select patients for stenoparib-based therapy.
The stenoparib-DRP® is comprised of a unique 414-gene expression signature, notably including genes associated with WNT pathway activity. At AACR 2026, Allarity presented an exploratory analysis of its prior Phase 2 cohort of patients with advanced ovarian cancer treated with twice-daily stenoparib. Higher pretreatment DRP scores were associated with longer overall survival, supporting the test’s potential to identify patients who may derive the most durable benefit.
Recent patent awards coupled with the CLIA certification of Allarity’s in-house lab allow the company to extend the utility of the test as a companion diagnostic test and to retain sole control of that clinical test. These developments extend the commercial viability of both stenoparib and the stenoparib-DRP test.
Collectively, these advances support Allarity’s ongoing strategy to use DRP to inform patient selection for a pivotal trial, making the technology an integral part of stenoparib’s development toward FDA approval.
“Over the past few months, we have significantly strengthened the clinical foundation for our DRP-guided stenoparib program,” said Thomas Jensen, Chief Executive Officer of Allarity Therapeutics. “For stenoparib, the association between higher DRP scores and longer overall survival helps inform our clinical development strategy as we work toward FDA approval. While stenoparib remains our principal development focus, our extensive experience developing predictors for other drugs also provides a foundation for external partnerships.”
About Allarity Therapeutics
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is developing stenoparib, a novel PARP/tankyrase inhibitor for patients with advanced ovarian cancer, and is using its proprietary DRP® technology to develop a companion diagnostic designed to identify patients expected to derive the greatest clinical benefit from stenoparib. Allarity’s principal operations are located in Denmark, and its U.S. business address is in Florida. For more information, visit www.allarity.com.
About Stenoparib/2X-121
Stenoparib is an orally available, small-molecule dual-targeted inhibitor of PARP1/2 and tankyrase 1/2. Tankyrases have emerged as potential therapeutic targets in cancer due in part to their role in regulating the WNT signaling pathway. Aberrant WNT/β-catenin signaling has been implicated in the development and progression of numerous cancers, including drug-resistant cancers. Through its inhibition of PARP and the WNT signaling pathway, stenoparib has the potential to provide therapeutic benefit across multiple cancer types, including ovarian cancer, small cell lung cancer and colorectal cancer.
Allarity has secured exclusive global rights to develop and commercialize stenoparib, which was originally developed by Eisai Co., Ltd. and was formerly known as E7449 and 2X-121.
Allarity has completed its first Phase 2 trial evaluating stenoparib in patients with advanced ovarian cancer. The trial demonstrated promising and durable clinical benefit in patients with ovarian cancer who received two or more prior lines of therapy and were treated with stenoparib twice daily. Updated data from the trial were presented at the AACR Special Conference on Advances in Ovarian Cancer in September 2025. These analyses remain subject to change as the study data mature.
Based on the emerging clinical experience with stenoparib, Allarity developed a new protocol focused on patients with platinum-resistant ovarian cancer, which began enrolling patients in the summer of 2025. The amended protocol enrolls only platinum-resistant or platinum-ineligible patients and is designed to advance the clinical development of stenoparib toward potential FDA approval.
In parallel, a separate Phase 2 trial evaluating stenoparib in combination with temozolomide for patients with relapsed small cell lung cancer, or SCLC, began enrolling in early 2026 and is currently enrolling patients at multiple U.S. Department of Veterans Affairs sites.
About the Drug Response Predictor – DRP® Companion Diagnostic
Allarity uses its drug-specific DRP® technology to identify patients who, based on the gene expression signature of their cancer, may be more likely to benefit from a particular drug. By screening patients before treatment, and selecting those with a sufficiently high, drug-specific DRP score, the DRP technology is designed to increase the likelihood of therapeutic benefit.
The DRP methodology is based on the comparisons of sensitive and resistant human cancer cell lines, and incorporates transcriptomic data, clinical tumor biology filters and prior clinical trial outcomes. The DRP uses messenger RNA expression profiles derived from patient biopsies to generate drug-specific predictive scores.
The DRP® platform has demonstrated the ability to provide statistically significant predictions of clinical outcome following drug treatment across dozens of retrospective and prospective clinical studies. The platform is designed for potential application across multiple cancer types, is patented for dozens of anti-cancer drugs and has been extensively described in peer-reviewed scientific literature.
Follow Allarity on Social Media LinkedIn: https://www.linkedin.com/company/allaritytx/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable federal securities laws. Forward-looking statements reflect current expectations or forecasts regarding future events. The words “anticipates,” “believes,” “continues,” “could,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “possible,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the potential of the DRP® platform to identify patients most likely to benefit from stenoparib and other therapies; Allarity’s plans to use DRP to inform patient selection for a potential pivotal trial of stenoparib; the potential for stenoparib to achieve FDA approval; the expected benefits of Allarity’s in-house CLIA laboratory capability, including support for patient-selection testing, the development of companion diagnostics and the delivery of laboratory services to external partners; opportunities for diagnostic licensing and other external partnerships; the scope and duration of Allarity’s patent protection; and the Company’s ability to create long-term enterprise value. Any forward-looking statements in this press release are based on management’s current expectations of future events and are subject to multiple risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the exploratory nature of the DRP analyses described in this press release and the possibility that such results may not be replicated in future clinical trials; the risk that the DRP may not successfully identify patients who benefit from stenoparib or other therapies; risks related to the design, timing, enrollment, conduct and results of clinical trials, including any potential pivotal trial of stenoparib; the risk that stenoparib or any DRP-based companion diagnostic may not receive regulatory approval; risks related to the operation of Allarity’s CLIA laboratory, including regulatory compliance; the Company’s ability to enter into and maintain licensing and laboratory services agreements with external partners; the Company’s ability to obtain, maintain, defend and enforce its patents and other intellectual property rights; the Company’s need for additional financing; and general market, economic and competitive conditions. For a discussion of risks and uncertainties and other important factors that could cause actual results to differ materially from those contained in the forward-looking statements, see the risk factors and other disclosures in Allarity’s filings with the SEC, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These filings are available through the SEC’s website. All information in this press release is as of the date of the release, and the Company undertakes no obligation to update or revise this information, except as required by applicable law.
###
Company Contact: investorrelations@allarity.com
Media Contact: Thomas Pedersen Carrotize PR & Communications +45 6062 9390 tsp@carrotize.com
ST. PETERSBURG, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) today announced that it will report its third quarter results after the market close on Thursday, October 29, 2026. Management will host a conference call on Friday, October 30, 2026, at 9:00 a.m. ET to discuss the results. The call will also be broadcast live via the internet.
Interested investors may listen to the call live under the Investor Relations tab at www.bayfirstfinancial.com. Investment professionals are invited to dial (833) 461-5787 to participate in the call using Conference ID 438809173. A replay of the call will be available for one year at www.bayfirstfinancial.com.
About BayFirst Financial Corp.
BayFirst Financial Corp. is a registered bank holding company based in St. Petersburg, Florida which commenced operations on September 1, 2000. Its primary source of income is derived from its wholly owned subsidiary, BayFirst National Bank, a national banking association which commenced business operations on February 12, 1999. The Bank currently operates eleven full-service banking offices throughout the Tampa Bay-Sarasota region and offers a broad range of commercial and consumer banking services to businesses and individuals. As of June 30, 2026, BayFirst Financial Corp. had $1.13 billion in total assets.
Forward-Looking Statements
In addition to the historical information contained herein, this presentation includes “forward-looking statements” within the meaning of such term in the Private Securities Litigation Reform Act of 1995. These statements are subject to many risks and uncertainties, including, but not limited to, the effects of health crises, global military hostilities, weather events, or climate change, including their effects on the economic environment, our customers and our operations, as well as any changes to federal, state or local government laws, regulations or orders in connection with them; the ability of the Company to implement its strategy and expand its banking operations; changes in interest rates and other general economic, business and political conditions, including changes in the financial markets; changes in business plans as circumstances warrant; risks related to mergers and acquisitions; changes in benchmark interest rates used to price loans and deposits, changes in tax laws, regulations and guidance; enforcement actions initiated by our regulators and their impact on our operations; and other risks detailed from time to time in filings made by the Company with the SEC, including, but not limited to those “Risk Factors” described in our most recent Form 10-K and Form 10-Q. Readers should note that the forward-looking statements included herein are not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking statements.
Gateway builds on its 2026 order of 100 W56s with a 200-vehicle expansion
Gateway builds on its 2026 order of 100 W56s, as fleet operator demand grows
W56 deployments continue alongside new Gateway site launches, with additional trucks supporting growth into 2027
DETROIT, Sept. 30, 2026 (GLOBE NEWSWIRE) — Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse”), an American Industrial Technology company, and Kingsburg Truck Center (KTC), a leading California truck dealer, today announced that Gateway Fleets has placed a follow-on purchase order for 200 W56 fully-electric step vans. Gateway, a California-based provider of turnkey electric vehicle and charging solutions for commercial delivery operators, is purchasing the vehicles through KTC with the intent to lease them to its customers, who are primarily last-mile independent package delivery providers.
Gateway’s business model bundles purpose-built electric trucks with charging infrastructure, fleet support, and depot access through flexible financing arrangements designed to simplify electric fleet operations. For Gateway, scale follows operator confidence. To build that confidence, Gateway is investing in the vehicles, infrastructure, and support required to keep operators moving every day.
Through Gateway’s lease structure, operators will gain the fuel and maintenance savings of electric vehicles while managing cash flow and avoiding large upfront capital expenditures. Gateway currently operates depots in Southern California and is scaling its network to meet growing operator demand across the region and beyond. For Workhorse, this purchase order expands a channel to delivery operators seeking a more accessible path to fleet electrification.
“In today’s era of high and volatile fuel prices, customers are seeking the stability and lower operating costs associated with electric trucks, without sacrificing safety or performance,” said Scott Griffith, Chief Executive Officer at Workhorse. “We believe Gateway’s innovative model will help unlock wider adoption of electric trucks through its bundled pricing that eliminates the two biggest barriers to widespread adoption: the higher upfront cost of the vehicle and the added investment capital required to build out the charging infrastructure.”
The W56 step vans available through Gateway are Standard Wheelbase (178″) configurations with a 210 kWh battery, offering 1,000 cubic feet of cargo space, a payload of 10,000 lbs. and a nominal range of 150 miles per charge. Every van features a fully-integrated, purpose-built composite body, an ergonomic driver environment, and a platform engineered for the demands of high-cycle last-mile delivery. Vehicles contracted in this new order are expected to begin deploying to customers in the second half of 2027, with deployments continuing through 2028.
“Getting the truck on the road is only the beginning. Keeping operators moving takes the right combination of infrastructure, service, and support,” said Jamie Miller, Chief Revenue Officer of Gateway Fleets. “Workhorse has brought us an innovative vehicle and a team committed to standing behind it, while Kingsburg provides the service expertise and support our customers need in the field. Gateway brings those pieces together with the charging infrastructure and capital to make electrification work for operators. As we open new locations, we’re continuing to expand W56 deployments alongside our network, with more sites and trucks coming online through ‘peak’ and into 2027. We’re excited to keep building on what’s working together.”
All W56 models are produced at Workhorse’s commercial-scale manufacturing facility in Union City, Indiana, which is capable of producing up to 5,000+ vehicles per year on a standard operating shift. To date, Workhorse has delivered more than 1,100 vehicles that have collectively accumulated more than 21 million real-world miles across customer fleets.
Vehicles contracted in this new order are expected to begin deploying in the second half of 2027 so that customers can deploy them fleetwide in advance of “peak” holiday season, when package delivery volumes spike.
“This partnership brings together three critical components of fleet electrification: a high quality, proven Workhorse truck; a deployment and service partner, Gateway; and our team at Kingsburg, providing full-circle consultative sales, incentive processing and service support,” said Jerry Smith, Owner at Kingsburg Truck Center. “We’ve had nothing but positive feedback on the performance of the W56 this year, and we’re looking forward to an even better 2027.”
Fleets interested in leasing a Workhorse W56 should contact Gateway Fleets directly or visit www.gatewayfleets.com.
About Workhorse Group Inc.
Headquartered in the Detroit area with a commercial-scale manufacturing plant in Union City, Indiana, Workhorse (Nasdaq: WKHS) is an American Industrial Technology company specializing in electrification, high-voltage systems integration, mobility platforms, ruggedized mobile platform manufacturing, distributed energy systems, and deployable industrial infrastructure. We manufacture durable, reliable and high-performing vehicles and infrastructure for mission-critical applications deployed in the world’s most demanding operating environments. More information is available at www.workhorse.com.
About Gateway Fleets
Gateway Fleets is a California-based provider of complete electric vehicle and charging solutions designed for commercial delivery operators. Gateway delivers electric trucks, fast flat-rate charging infrastructure, real-time fleet visibility and support, and depot access in a single bundled package — removing the barriers to electric fleet adoption and enabling operators to focus on their routes. Gateway Fleets currently serves operators in Southern California and is expanding to meet growing demand. More information is available at www.gatewayfleets.com.
About Kingsburg Truck Center
Based in Kingsburg, California, Kingsburg Truck Center is one of the nation’s leading commercial truck dealerships and was the first full-service authorized dealer for Workhorse Group Inc. in the state of California. Specializing in advanced vocational solutions and zero-emission fleet deployment, Kingsburg Truck Center provides comprehensive upfitting, sales, and service for the medium-duty market. The company is a recognized leader in California’s incentive ecosystem, leveraging deep expertise in grant writing and voucher processing to maximize funding for fleet transitions. As a strategic partner for sustainable transportation, Kingsburg Truck Center helps operators navigate technical and financial complexities to achieve zero-emission goals. More information is available at kingsburgtruckcenter.com.
Contacts:
Workhorse John Williams, Communications +1-206-660-5503, john.williams@workhorse.com
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Exchange Act, and the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical fact included in this press release, including statements regarding the planned delivery of vehicles to Gateway Fleets, Gateway Fleets’ intended leasing activities, anticipated fleet operator demand for electric vehicles, and the expected deployment timing of purchased trucks, and the production capacity of Workhorse’s Union City facility, are forward-looking statements. Some of these statements may be identified by the use of the words “plans”, “expects” or “does not expect”, “estimated”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, “targets”, “projects”, “contemplates”, “predicts”, “potential”, “continue”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might”, “will” or “will be taken”, “occur” or “be achieved”.
Forward-looking statements are based on the opinions and estimates of management of Workhorse as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Some factors that could cause actual results to differ include our ability to raise capital to fund our operations and to maintain access to our current debt facilities; our ability to achieve the expected synergies and/or efficiencies from our operations and as a result of the Motiv/Workhorse merger; our ability to reduce the cost to build our vehicles; our ability to hire and retain the workforce needed; changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting our business, including demand for electric trucks and our cost of production; and our ability to maintain compliance with Nasdaq rules and otherwise maintain our listing of securities on Nasdaq.
Additional information on these and other factors that may cause actual results and Workhorse’s performance to differ materially is included in Workhorse’s periodic reports filed with the SEC, including Workhorse’s Annual Report on Form 10-K for the year ended December 31, 2025 including those factors described under the heading “Risk Factors” therein, and Workhorse’s subsequent Quarterly Reports on Form 10-Q. Copies of Workhorse’s filings with the SEC are available publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Workhorse. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and Workhorse undertakes no obligation to update or revise the forward-looking statements except as required by law.
90-minute “Longmenzhen” Marathon Q&A to take questions from both the in-person audience and livestream viewers
LAS VEGAS, Sept. 30, 2026 (GLOBE NEWSWIRE) — All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today announced that it will host the AIFA 2026 Annual Gathering at the AIFA Arena in Las Vegas on October 3-4, 2026. October 3 will be Community Day, and October 4 will be Main Day.
The main hall program will be livestreamed in full on WeChat Channels (account: 李尚龙, Li Shanglong) and https://www.youtube.com/@hyperxarenaLV, beginning at 6:00 p.m. Pacific Time on October 4 (9:00 a.m. Beijing Time on October 5).
Event Highlights
Chairman’s Keynote. Chairman Li Shanglong will present the Company’s annual strategy, including its platform positioning for the global Chinese community and its next phase of development.
“Longmenzhen” Marathon Q&A. For 90 minutes, the Chairman and the management team will take questions in turn from the in-person audience and livestream viewers. The session will be bilingual in English and Chinese with simultaneous interpretation, and questions will not be pre-screened.
Four Business Track Expo. The expo is organized around four tracks: Education, Going Global, Local Life, and Content Creation, reflecting the core business focus outlined in the Company’s recent announcement. [AIFA corporate website: AIFA-global.com]
Creators and Partners. The Company’s signed knowledge creators, academics including a professor at the Stanford University School of Medicine, and education partners will take part in on-site programming and content co-creation. The Company’s video content network has surpassed one billion total views.
“This is the first annual gathering since our new team took office. We want to explain, face to face, what the Company is doing and where it is headed. And we are leaving the hardest questions for the audience to ask,” said Li Shanglong, Chairman of AIFA.
How to Watch
Search “李尚龙” on WeChat Channels and https://www.youtube.com/@hyperxarenaLV. The livestream begins at 6:00 p.m. Pacific Time on October 4 (9:00 a.m. Beijing Time on October 5). A replay will be available on the investor relations section of the Company’s website: [ir.aifa-global.com]
About All In FutureTech Alliance Inc. All In FutureTech Alliance Inc. (NASDAQ: AIFA) is a publicly listed company focused on applying artificial intelligence to real-world business and service scenarios. The Company is developing businesses across education and workforce development, AI-enabled services, media and creator services, global commerce, and investment and research.
AIFA seeks to use artificial intelligence to improve knowledge creation, identify user needs, enhance resource matching and increase the efficiency and scalability of professional service delivery. The Company’s long-term objective is to build a scalable, AI-enabled global service platform serving individuals, organizations and businesses across multiple markets.
Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable U.S. federal securities laws. These statements may include, without limitation, statements regarding the Company’s strategic direction, business development plans, use of artificial intelligence, anticipated expansion of its business platform, development of its education, media, global commerce, investment and research activities, and its long-term objective of building a scalable, AI-enabled global service platform.
Forward-looking statements are based on current expectations, estimates and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, among others, the Company’s ability to execute its business strategy, develop and commercialize its products and services, expand its customer and partner base, manage regulatory and compliance requirements, compete effectively, integrate new business initiatives, and obtain financing or other resources as needed.
Readers are cautioned not to place undue reliance on these forward-looking statements. Additional information regarding risks and uncertainties affecting the Company is contained in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements, except as required by applicable law.
Institutional Credit Layer on HyperEVM Secured by Collateral in Qualified Custody at a Federally Chartered Bank
DALLAS, Sept. 30, 2026 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced the launch of the first institutional credit facility on HyperLend’s Aviya Finance platform, utilizing Anchorage Digital’s regulated settlement infrastructure.
In an industry first, the borrower’s obligations are secured by natively-staked HYPE tokens held in qualified custody at Anchorage Digital Bank, N.A., the first federally chartered digital asset bank. The announcement coincides with the launch of Aviya Finance, the permissioned institutional credit venue powered by HyperLend’s proven onchain lending infrastructure, and its integration with Anchorage Digital’s regulated settlement and collateral network, Atlas.
“Today marks a key step towards expanding access to onchain liquidity for real-world assets on Hyperliquid,” said Hyunsu Jung, Chief Executive Officer of Hyperion DeFi. “It starts with creating this secured, white-listed credit facility backed by natively staked HYPE tokens held in qualified custody. From this foundation, the roadmap is to scale as assets continue to move onchain, supporting users with enterprise-grade infrastructure built alongside our partners.”
“Institutions have wanted access to onchain credit, but not at the expense of the safeguards they rely on. This facility shows those two things don’t have to be traded off. Collateral stays natively staked in qualified custody, and through Atlas it can be pledged, released, and monitored around the clock,” said Nathan McCauley, CEO and Co-Founder at Anchorage Digital. “That is the kind of infrastructure that lets institutional capital participate in the Hyperliquid ecosystem with confidence.”
“150 million HYPE is staked with validators outside of Hyperliquid Labs and the Foundation, representing over $10 billion in assets earning staking yield, but unable to work simultaneously as collateral,” said Benjamin Sever, CEO and Co-Founder at HyperLend. “Today, Aviya unlocks this capital, providing institutions that require qualified custody of their assets to access credit onchain without leaving custody. Starting with HYPE and its staked derivatives, Aviya will continue to add more collateral types as demand grows. The magnitude and velocity of capital on Hyperliquid is accelerating, and Aviya is positioned to lead institutional fixed-rate borrowing and lending of digital and real-world assets on Hyperliquid.”
The facility is protected by customary off-chain legal agreements, margin maintenance, liquidation, and collateral monitoring provisions, including specified loan-to-value thresholds and liquidation triggers. The infrastructure is designed with the goal of institutional scalability.
This collaboration supports Hyperion DeFi’s diversified products suite servicing institutional clients, including the Company’s validator operations, its yield vault infrastructure, the HYPE Asset Use Service (HAUS), supporting permissionless Hyperliquid markets including EntropyIO (HIP-3) and Skew (HIP-4), and the credit layer built on Aviya Finance. Hyperion DeFi plans to continue generating value from strategic participation in network growth initiatives available exclusively on Hyperliquid.
About the Hyperliquid Platform and the HYPE Token
Hyperliquid is a next-generation layer one blockchain optimized for high frequency, transparent trading. The blockchain includes fully on-chain perpetual futures and spot order books, with every order, cancel, trade, and liquidation occurring within 70 millisecond block times. It also hosts the HyperEVM, a general-purpose smart contract platform that supports permissionless decentralized financial applications akin to Ethereum.
HYPE is the native token of Hyperliquid. Staked HYPE provides utility for users via reduced trading fees and increased referral bonuses. As of September 2026, more than 47 million HYPE have been autonomously purchased and sequestered by the blockchain with the trading fees generated on the network’s central limit order books.
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc. is the first U.S. publicly listed DeFi company building on Hyperliquid. The Company provides investors with streamlined access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-generating blockchains in the world. Shareholders benefit from compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its unique on-chain utility.
Anchorage Digital is the proven infrastructure layer for modern financial markets that gives institutions a single platform to participate in digital assets, including prime services, tokenization, stablecoins, and the governance framework for agentic finance. Home to Anchorage Digital Bank N.A., America’s first federally regulated digital asset bank, Anchorage Digital also serves institutions through Anchorage Digital Singapore, licensed by the Monetary Authority of Singapore; Anchorage Digital NY, which holds a BitLicense from the New York Department of Financial Services; and self-custody wallet Porto by Anchorage Digital. Anchorage Digital Bank also offers fiat custody services through an FDIC-insured, licensed sub-custodian. Anchorage Digital is funded by leading institutions including Andreessen Horowitz, GIC, Goldman Sachs, KKR, and Visa, with a valuation of $4.2 billion. Founded in 2017 in San Francisco, California, Anchorage Digital has offices in New York, New York; Porto, Portugal; Singapore; and Sioux Falls, South Dakota. Learn more at anchorage.com, X, YouTube, and LinkedIn.
About HyperLend
HyperLend is the decentralized lending protocol functioning as the credit layer of Hyperliquid. HyperLend is foundational to the entire Hyperliquid ecosystem, servicing both HyperCore and HyperEVM with the layer that is necessary to continually increase capital velocity. HyperLend has recently launched Aviya Finance, it’s institutional credit venue, offering fixed rate loans against HYPE, its derivatives and further assets on Hyperliquid. With over $800 Million in market size, HyperLend has built an impressive track record, providing market leading lending and borrowing interest rates and liquidity for its users. As Hyperliquid continues to form as the house of all finance HyperLend is positioned to scale alongside it, continuing its mission to make decentralized credit as powerful and accessible as its traditional counterparts.
Forward Looking Statements
Except for historical information, all the statements, expectations and assumptions contained in this press release are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements, our future activities or other future events or conditions, including the viability of, and risks associated with, our cryptocurrency treasury strategy, the growth and revenue potential of the Hyperliquid ecosystem and the growth prospects of the Company. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which we file with the U.S. Securities and Exchange Commission.
Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, Hyperion DeFi does not undertake any obligation to update any forward-looking statements.
